Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT03941756
- Status
- Recruiting
Conditions
- Anatomic Stage III Breast Cancer AJCC v8
- Breast Inflammatory Carcinoma
- Locally Advanced Breast Carcinoma
- Melanoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Indocyanine Green — DRUGGiven IV
- Lymphangiography — PROCEDUREUndergo lymphangiography
- Lymphovenous Bypass — PROCEDUREUndergo LVB
Study Details
This pilot trial studies whether a procedure called lymphovenous bypass would prevent lymphedema (arm swelling) in patients with inflammatory breast cancer or non-inflammatory breast cancer that has spread to nearby tissues or lymph nodes or melanoma. The lymphovenous bypass procedure creates a path for lymphatic fluid to flow away from the arms. It is usually done after a diagnosis of lymphedema. In this study, giving lymphovenous bypass before underarm lymph node surgery may help prevent lymphedema from forming.
Key Dates
- Start date
- Aug 14, 2018
- Status verified
- May 2026
- Primary completion
- Jan 1, 2027
- Completion
- Dec 1, 2027
Study Design
- Enrollment
- 252 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: Group I (LVB)Patients receive indocyanine green IV and undergo lymphangiography, then undergo LVB at the time of ALND.
- No Intervention: Group II (no intervention)Patients do not receive indocyanine green, undergo lymphangiography, nor undergo LVB at the time of ALND.
Primary Outcome Measure
Volumetric diagnosis of lymphedema [ Time Frame: 18 months ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| M D Anderson Cancer Center | Houston | Texas | 77030 | Mark Schaverien (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By condition
By specialty
By research site
Related Studies
- Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy ProgramRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)PHASE1/PHASE2 · Recruiting · Merck Sharp & Dohme LLC · Aurora, Colorado
- Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast CancerRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- Dabrafenib and/or Trametinib Rollover StudyPHASE4 · Recruiting · Novartis Pharmaceuticals · Scottsdale, Arizona